Exclusive: Gene therapy manufacturing facility grows to $200M with investment

Andelyn-Biosciences-Logo

Andelyn Biosciences, the biotech manufacturing spinout of Nationwide Children’s, is again doubling capacity of its Columbus facility following its first outside investment.

Click here to read the complete story.

Story excerpt provided by Columbus Business First. See related article in The Columbus Dispatch.

Written by Carrie Ghose.

Originally published March 18, 2021.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: